A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
3.70 -0.04 (-1.06%) IMMU

Click Here to Receive Instant E-mail and RSS Alerts


Trade IMMU now with

Stock Details

Last Trade:3.70 Change:-0.04 (-1.06%) Prev Close:3.74 Open: 3.78 Days Range:3.69 – 3.78 52 Week Range: 2.85 - 4.47 Volume:229171 P/E: N/A
EPS:-0.19

Member Comments

No member comments available for IMMU


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/08/12 at 8:32am
Immunomedics, Inc. (IMMU) Trumps Q2 EPS, Revenue Views

Immunomedics, Inc. (NASDAQ: IMMU) reported Q2 EPS of $0.27, $0.35 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $29.7 million versus the consensus estimate of $11.47 million. For earnings history and... Read More

Recent Alert on 12/28/11 at 9:22am
Pre-Open Movers 12/28: (IMMU) (END) (NBL) Higher; (CAVM) (SHLD) (MRX) Lower (more...)
Recent Alert on 12/28/11 at 6:47am
Immunomedics (IMMU) Epratuzumab Agreement w/ UCB S.A. Now Worth ~$68M
Recent Alert on 12/28/11 at 6:47am
Immunomedics (IMMU) Epratuzumab Agreement w/ UCB S.A. Now Worth ~$68M
Recent Alert on 12/14/11 at 8:37am
Immunomedics (IMMU) Receives US Patent 8,076,140 for Improved Cell Lines for Protein Therapeutic Manufacturing

View AllRecent Press Releases

Press Release on 02/08/12 at 8:30am
Immunomedics Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments

View AllRecent SEC Filings

SEC Filing on 02/08/12 at 12:02pm
Form SC 13G IMMUNOMEDICS INC Filed by: VANGUARD GROUP INC
SEC Filing on 02/08/12 at 8:42am
Form 10-Q IMMUNOMEDICS INC For: Dec 31
SEC Filing on 02/08/12 at 8:31am
Form 8-K IMMUNOMEDICS INC For: Feb 08

View AllRecent Blog Posts

Blog Posts on 01/31/12 at 3:51pm
Small Biotech Companies With Big, Promising Pipelines
Blog Posts on 11/08/11 at 5:31pm
IPO Preview: NewLink Genetics
Blog Posts on 10/26/11 at 6:37am
Today's Weakness In Human Genome Offers An Attractive Entry For Bulls
Blog Posts on 10/25/11 at 8:14am
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Blog Posts on 08/31/11 at 4:38pm
3 Promising, Inexpensive Analyst Picks, And How To Hedge Your Risk With Them